How many insider trades does FilingIQ track for BJDX?

FilingIQ tracks 33 Form 4 insider transactions for BJDX (Bluejay Diagnostics, Inc.), covering filings from Mar 14, 2022 onwards. 2 of those were filed in the last 90 days.

Are BJDX insiders net buyers or net sellers?

Across the full Form 4 history for BJDX, 20 transactions (61%) were open-market purchases and 1 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does BJDX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is BJDX in?

Bluejay Diagnostics, Inc. (BJDX) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $3.99M.

BJDX insider trading

NasdaqCM Healthcare

Bluejay Diagnostics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

61% / 3%

Market cap

$3.99M

About Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Company website: bluejaydx.com

BJDX insider activity at a glance

FilingIQ has scored 33 insider transactions for BJDX since Mar 14, 2022. The most recent filing in our index is dated Jul 10, 2026.

Across the full history, 20 open-market purchases and 1 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BJDX insider trades is 66.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live BJDX trades on FilingIQ Raw filings on SEC EDGAR

Latest BJDX Form 4 filings

Dey Indranil President and CEO

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,070

UNITED THERAPEUTICS Corp

APLS 272

Apellis Pharmaceuticals, Inc.

NUVL 218

Nuvalent, Inc.

KYMR 215

Kymera Therapeutics, Inc.

HNGE 194

Hinge Health, Inc.

GH 189

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for BJDX?: FilingIQ tracks 33 Form 4 insider transactions for BJDX (Bluejay Diagnostics, Inc.), covering filings from Mar 14, 2022 onwards. 2 of those were filed in the last 90 days.
Are BJDX insiders net buyers or net sellers?: Across the full Form 4 history for BJDX, 20 transactions (61%) were open-market purchases and 1 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BJDX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is BJDX in?: Bluejay Diagnostics, Inc. (BJDX) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $3.99M.

Methodology & sources

Every BJDX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.